Trigliseritler, Total Kolesterol ve Vücut Ağırlığı İndeksi’nin Metabolik Sendrom için Yüksek Tanısal Performans Göstermesi: Yerleşik Kardiyometabolik ve İnflamatuar İndekslerle Karşılaştırmalı Bir Çalışma

Öz

Amaç: Bu çalışma, metabolik sendrom (MetS) hastalarında kompozit inflamatuvar ve kardiyometabolik indekslerin tanısal performansını, özellikle trigliserid, total kolesterol ve vücut ağırlığı indeksine (TCBI) odaklanarak değerlendirmeyi amaçlamıştır. Yöntemler: Bu retrospektif, tek merkezli çalışmaya, Ocak 2023 ile Ocak 2026 tarihleri arasında iç hastalıkları kliniğine başvuran 18–65 yaş arası bireyler dahil edilmiştir. MetS tanısı NCEP ATP III kriterlerine göre konulmuştur. Demografik, antropometrik ve laboratuvar verileri elektronik tıbbi kayıtlardan elde edilmiştir. Rutin biyokimyasal ve hematolojik parametrelere ek olarak TCBI, TyG, CMI, CRP/HDL, NHR, UHR, NLAR, PIV, HALP, NLR, SIRI ve SII gibi kompozit indeksler standart formüller kullanılarak hesaplanmıştır. Gruplar arası karşılaştırmalar uygun istatistiksel testlerle yapılmıştır. İndekslerin tanısal performansını değerlendirmek amacıyla alıcı işletim karakteristiği (ROC) eğrisi analizi uygulanmıştır. Bulgular: Çeşitli antropometrik ve metabolik parametreler açısından gruplar arasında anlamlı farklılıklar saptanmıştır (p < 0.05). Değerlendirilen indeksler arasında TCBI, CMI, TyG, CRP/HDL, NHR ve UHR düzeyleri MetS hastalarında anlamlı olarak yüksek bulunurken (p < 0.0001), NLAR, PIV, HALP, NLR, SIRI ve SII açısından anlamlı fark gözlenmemiştir (p > 0.05). ROC analizi, en yüksek tanısal performansın TCBI’ye ait olduğunu göstermiştir (AUC: 0.9622, %95 GA: 0.9378–0.9865, p < 0.0001); bunu CMI (AUC: 0.9600) ve TyG (AUC: 0.9463) izlemiştir. CRP/HDL, NHR ve UHR orta düzeyde ayırt edici performans sergilemiştir. Sonuç: TCBI, bu kohortta güçlü tanısal performans gösterdi ve değerlendirilen indekslerle karşılaştırıldığında daha yüksek genel ayırt edici kapasite sergiledi. Bu bulgular, TCBI’nin MetS değerlendirmesinde basit ve kolay erişilebilir bir belirteç olabileceğini düşündürmektedir. Ancak, klinik kullanım potansiyelinin doğrulanabilmesi için ileri çalışmalara ihtiyaç vardır.

Anahtar Kelimeler

• Metabolik sendrom
• Trigliseritler, total kolesterol ve vücut kitle indeksi
• Kompozit biyobelirteçler
• Kardiyometabolik indeks
• Sistemik inflamasyon

Destekleyen Kurum

Yazarlar, bu çalışma için finansal destek almadığını beyan etmiştir.

Etik Beyan

Çalışmanın etik onayı Malatya Turgut Özal Üniversitesi Sağlık Bilimleri Bilimsel Araştırmalar Etik Kurulu'ndan alınmıştır (Tarih: 02/04/2026, Sayı: 2026/139).

Triglycerides, Total Cholesterol, and Body Weight Index Demonstrates High Discriminative Performance for Metabolic Syndrome: A Comparative Study with Established Cardiometabolic and Inflammatory Indices

Öz

Objective: This research sought to assess the effectiveness of combined inflammatory and cardiometabolic markers, with a particular focus on the triglycerides, total cholesterol, and body weight index (TCBI), in individuals diagnosed with metabolic syndrome (MetS). Methods: This retrospective, single-center study included individuals aged 18-65 years who were admitted to the internal medicine clinic between January 2023 and January 2026. MetS was defined according to NCEP ATP III criteria. Demographic, anthropometric, and laboratory data were obtained from electronic medical records. In addition to routine biochemical and hematological parameters, composite indices including TCBI, TyG, CMI, CRP/HDL, NHR, UHR, NLAR, PIV, HALP, NLR, SIRI, and SII were calculated using standard formulas. Appropriate statistical tests were utilized to compare groups. To evaluate the diagnostic effectiveness of the indices, a ROC curve analysis was performed. Results: Several anthropometric and metabolic parameters differed significantly between groups (p < 0.05). Among the evaluated indices, TCBI, CMI, TyG, CRP/HDL, NHR, and UHR levels were significantly elevated in MetS patients (p < 0.0001), whereas NLAR, PIV, HALP, NLR, SIRI, and SII showed no significant differences (p > 0.05). ROC analysis demonstrated that TCBI had the highest diagnostic performance (AUC: 0.9622, 95% CI: 0.9378 - 0.9865, p < 0.0001), followed by CMI (AUC: 0.9600) and TyG (AUC: 0.9463). CRP/HDL, NHR, and UHR exhibited moderate discriminative ability. Conclusion: TCBI showed strong diagnostic performance in this cohort and demonstrated higher overall discriminative ability compared with the evaluated indices. These findings suggest that TCBI may represent a simple and accessible marker for MetS assessment. However, further studies are required to validate its clinical utility.

Anahtar Kelimeler

• Metabolic syndrome
• Triglycerides, total cholesterol, and body weight index
• Composite biomarkers
• Cardiometabolic index
• Systemic inflammation

Destekleyen Kurum

The authors declared that this study has received no financial support.

Etik Beyan

Ethical approval of the study was received from the Malatya Turgut Özal University Health Sciences Scientific Research Ethics Committee (Date: 02/04/2026, Number: 2026/139).

Kaynakça

1. Abacı, A., Kılıçkap, M., Göksülük, H., Karaaslan, D., Barçın, C., Kayıkçıoğlu, M., Özer, N., Yılmaz, M. B., Şahin, M., & Tokgözoğlu, L. (2018). Türkiye’de metabolik sendrom sıklığı verileri: Kardiyovasküler risk faktörlerine yönelik epidemiyolojik çalışmaların sistematik derleme, meta-analiz ve meta-regresyonu. Türk Kardiyoloji Derneği Arşivi, 46, 591–601. https://doi.org/10.5543/tkda.2018.00878
2. Aktaş, G., Koçak, M. Z., Bilgin, S., Atak, B. M., Duman, T. T., & Kurtkulagi, O. (2020). Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male, 23(5), 1098–1102. https://doi.org/10.1080/13685538.2019.1678126
3. Assani, M. Z., Boldeanu, L., Dijmărescu, A. L., Caragea, D. C., Vladu, I. M., Clenciu, D., Mitrea, A., Stroe-Ionescu, A. Ș., Caragea, M. E., Siloși, I., & Boldeanu, M. V. (2025). Beyond HOMA-IR: Comparative evaluation of insulin resistance and anthropometric indices across prediabetes and type 2 diabetes mellitus in metabolic syndrome patients. Life, 15(12), 1845. https://doi.org/10.3390/life15121845
4. Chen, T., Chen, H., Xiao, H., Tang, H., Xiang, Z., Wang, X., Wang, X., & Zou, H. (2020). Comparison of the value of neutrophil to high-density lipoprotein cholesterol ratio and lymphocyte to high-density lipoprotein cholesterol ratio for predicting metabolic syndrome among a population in the southern coast of China. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 13, 597–605. https://doi.org/10.2147/DMSO.S238990
5. Chen, X. L., Xue, L., Wang, W., Chen, H. N., Zhang, W. H., Liu, K., Chen, X. Z., Yang, K., Zhang, B., Chen, Z. X., Chen, J. P., Zhou, Z. G., & Hu, J. K. (2015). Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: A retrospective cohort study. Oncotarget, 6(38), 41370–41382. https://doi.org/10.18632/oncotarget.5629
6. Djesevic, M., Hasic, S., Lepara, O., Jahic, R., Kurtovic, A., & Fajkic, A. (2023). CRP/HDL-C and monocyte/HDL-C ratios as predictors of metabolic syndrome in patients with type 2 diabetes mellitus. Acta Informatica Medica, 31(4), 254–259. https://doi.org/10.5455/aim.2023.31.254-259
7. Doi, S., Iwata, H., Wada, H., Funamizu, T., Shitara, J., Endo, H., Naito, R., Konishi, H., Tsuboi, S., Ogita, M., Dohi, T., Kasai, T., Okazaki, S., Isoda, K., Miyauchi, K., & Daida, H. (2018). A novel and simply calculated nutritional index serves as a useful prognostic indicator in patients with coronary artery disease. International Journal of Cardiology, 262, 92–98. https://doi.org/10.1016/j.ijcard.2018.02.039
8. Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., & Assi, H. I. (2022). Metabolic syndrome: Updates on pathophysiology and management in 2021. International Journal of Molecular Sciences, 23(2), 786. https://doi.org/10.3390/ ijms23020786.

9. Fan, L., Su, Y., Chen, Y., Xu, L., Huang, H., Lu, C., Peng, J., Sun, Y., & Jia, M. (2025). Triglyceride-cholesterol-body weight index associated with the risk of metabolic dysfunction-associated steatotic liver disease: A population-based cross-sectional study. Frontiers in Nutrition, 12, 1698297. https://doi.org/10.3389/fnut.2025.1698297
10. Faul, F., Erdfelder, E., Buchner, A., & Lang, A. G. (2009). Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods, 41(4), 1149–1160. https://doi.org/10.3758/BRM.41.4.1149
11. Fucà, G., Guarini, V., Antoniotti, C., Morano, F., Moretto, R., Corallo, S., Marmorino, F., Lonardi, S., Rimassa, L., Sartore-Bianchi, A., Borelli, B., Tampellini, M., Bustreo, S., Claravezza, M., Boccaccino, A., Murialdo, R., Zaniboni, A., Tomasello, G., Loupakis, F., … Pietrantonio, F. (2020). The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials. British Journal of Cancer, 123(3), 403–409. https://doi.org/10.1038/s41416-020-0894-7
12. Gao, J., Lu, J., Sha, W., Xu, B., Zhang, C., Wang, H., Xia, J., Zhang, H., Tang, W., & Lei, T. (2022). Relationship between neutrophil to high-density lipoprotein cholesterol ratio and severity of coronary artery disease. Frontiers in Cardiovascular Medicine, 9, 1015398. https://doi.org/10.3389/fcvm.2022.1015398
13. Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., Jr., Spertus, J. A., Costa, F., American Heart Association, & National Heart, Lung, and Blood Institute. (2005). Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation, 112(17), 2735–2752. https://doi.org/10.1161/CIRCULATIONAHA.105.169404
14. Guthrie, G. J. K., Charles, K. A., Roxburgh, C. S. D., Horgan, P. G., McMillan, D. C., & Clarke, S. J. (2013). The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer. Critical Reviews in Oncology/Hematology, 88(1), 218–230. https://doi.org/10.1016/j.critrevonc.2013.03.010
15. Hashemi, S. M., Kheirandish, M., Rafati, S., Ghazalgoo, A., Amini-Salehi, E., Keivanlou, M. H., Abbaszadeh, S., Saberian, P., & Rahimi, A. (2024). The association between neutrophil and lymphocyte to high-density lipoprotein cholesterol ratio and metabolic syndrome among Iranian population: Findings from Bandare Kong cohort study. Lipids in Health and Disease, 23(1), 393. https://doi.org/10.1186/s12944-024-02378-5
16. Hu, B., Yang, X. R., Xu, Y., Sun, Y. F., Sun, C., Guo, W., Zhang, X., Wang, W. M., Qiu, S. J., Zhou, J., & Fan, J. (2014). Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clinical Cancer Research, 20(23), 6212–6222. https://doi.org/10.1158/1078-0432.CCR-14-0442
17. Kıran, T. R., Ayyıldız, G., Keskin, L., & Erdem, M. (2026). Unveiling the significance of netrin-1 and netrin-4 in metabolic syndrome. Scientific Reports, 16(1), 5814. https://doi.org/10.1038/s41598-026-36172-3
18. Kıran, T. R., Keskin, L., Erdem, M., Güçtekin, Z., & İnceoğlu, F. (2026a). Association of HIF1α, BNIP3, and BNIP3L with hypoxia-related metabolic stress in metabolic syndrome. Medicina (Kaunas), 62(1), 166. https://doi.org/10.3390/medicina62010166
19. Koçak, M. Z., Aktaş, G., Erkuş, E., Sincer, I., Atak, B., & Duman, T. (2019). Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Revista da Associação Médica Brasileira, 65(1), 9–15. https://doi.org/10.1590/1806-9282.65.1.9
20. Kolahi Ahari, R., Akbari, N., Babaeepoor, N., Fallahi, Z., Saffar Soflaei, S., Ferns, G., Ebrahimi, M., Moohebati, M., Esmaily, H., & Ghayour-Mobarhan, M. (2024). Association of three novel inflammatory markers: Lymphocyte to HDL-C ratio, high-sensitivity C-reactive protein to HDL-C ratio and high-sensitivity C-reactive protein to lymphocyte ratio with metabolic syndrome. Endocrinology, Diabetes & Metabolism, 7(3), e00479. https://doi.org/10.1002/edm2.479
21. Liu, K., Tang, S., Liu, C., Ma, J., Cao, X., Yang, X., Zhu, Y., Chen, K., Liu, Y., Zhang, C., & Liu, Y. (2024). Systemic immune-inflammatory biomarkers (SII, NLR, PLR and LMR) linked to non-alcoholic fatty liver disease risk. Frontiers in Immunology, 15, 1337241. https://doi.org/10.3389/fimmu.2024.1337241
22. Noubiap, J. J., Nansseu, J. R., Nyaga, U. F., Ndoadoumgue, A. L., Ngouo, A. T., Tounouga, D. N., Tianyi, F. L., Foka, A. J., Lontchi-Yimagou, E., Nkeck, J. R., & Bigna, J. J. (2025). Worldwide trends in metabolic syndrome from 2000 to 2023: A systematic review and modelling analysis. Nature Communications, 17(1), 573. https://doi.org/10.1038/s41467-025-67268-5
23. Reilly, S. M., & Saltiel, A. R. (2017). Adapting to obesity with adipose tissue inflammation. Nature Reviews Endocrinology, 13(11), 633–643. https://doi.org/10.1038/nrendo.2017.90
24. Saltiel, A. R., & Olefsky, J. M. (2017). Inflammatory mechanisms linking obesity and metabolic disease. The Journal of Clinical Investigation, 127(1), 1–4. https://doi.org/10.1172/JCI92035
25. Son, D. H., Lee, H. S., Lee, Y. J., Lee, J. H., & Han, J. H. (2022). Comparison of triglyceride-glucose index and HOMA-IR for predicting prevalence and incidence of metabolic syndrome. Nutrition, Metabolism and Cardiovascular Diseases, 32(3), 596–604. https://doi.org/10.1016/j.numecd.2021.11.017
26. Tamini, S., Bondesan, A., Caroli, D., & Sartorio, A. (2024). The lipid accumulation product index (LAP) and the cardiometabolic index (CMI) are useful for predicting the presence and severity of metabolic syndrome in adult patients with obesity. Journal of Clinical Medicine, 13(10), 2843. https://doi.org/10.3390/jcm13102843
27. Thang, N. V. V., Luyen, L. T., Vi, N. T. T., & Hai, P. D. (2025). Neutrophil-to-lymphocyte-to-albumin ratio as a prognostic marker for mortality in sepsis and septic shock in Vietnam. Acute and Critical Care, 40(2), 244–251. https://doi.org/10.4266/acc.003576
28. Wang, Y., Mo, D., Hu, W., Zhong, Y., Li, Z., Ma, H., Jiang, N., Wang, T., & Yu, X. (2026). Comparison of novel nutritional index (TCBI) and insulin resistance index (TyG-BMI) for assessing cardiovascular disease risk: A cohort study. Journal of Health, Population and Nutrition, 45(1), 66. https://doi.org/10.1186/s41043-025-01234-1
29. Wei, X., Min, Y., Song, G., Ye, X., & Liu, L. (2024). Association between triglyceride-glucose related indices with the all-cause and cause-specific mortality among the population with metabolic syndrome. Cardiovascular Diabetology, 23(1), 134. https://doi.org/10.1186/s12933-024-02215-0
30. Xu, Y. (2025). Association of neutrophil/high-density lipoprotein cholesterol ratio with the cardiovascular-kidney-metabolic syndrome and its cardiovascular mortality. Frontiers in Nutrition, 12, 1594041. https://doi.org/0.3389/fnut.2025.1594041
31. Yoldaş, M. A., & Bolu, S. (2025). Serum uric acid to HDL-cholesterol ratio: A novel indicator for metabolic syndrome risk in children. Current Medical Research and Opinion, 41(7), 1239–1247. https://doi.org/10.1080/03007995.2025.2546949
32. Zhao, S., Dong, S., Qin, Y., Wang, Y., Zhang, B., & Liu, A. (2023). Inflammation index SIRI is associated with increased all-cause and cardiovascular mortality among patients with hypertension. Frontiers in Cardiovascular Medicine, 9, 1066219. https://doi.org/10.3389/fcvm.2022.1066219